The US Artificial Tears Market Size was $749.18 Million in 2023

The US Artificial Tears Market Overview

According to Global Market Monitor, the US artificial tears market size was $749.18 million in 2023 and is expected to grow to $968.23 million by 2028. Artificial tears are lubricating eye drops used to treat dry keratoconjunctivitis (dry eye disease) and dryness and irritation caused by insufficient tear production, as well as to moisten contact lenses and perform eye exams.

The Growing Incidence of Dry Eye has Increased the Demand for Artificial Tears.

Dry eye is a kind of disease that causes eye discomfort and visual dysfunction, which affects patients' work and quality of life. Severely affected, artificial tears are the usual first-line treatment. According to the US National Institute of Health and Health Survey, DED is diagnosed in 6.8% of the adult population (approximately 16.4 million people) in the United States. And the incidence of dry eye is increasing in various regions. This phenomenon brings opportunities to the artificial tears market.Aging is one of the most common causes of dry eyes because the production of tears decreases with age. The increase in the elderly population has boosted demand for artificial tears.

Market Competition Status

The top three companies are Johnson & Johnson, Allergan, and Bausch & Lomb with market shares of 15.31%, 14.35%, and 10.51% in 2022.

Johnson & Johnson is one of the major players operating in the artificial tears market, holding a share of 15.31% in 2022. It manufactures healthcare products and provides related services for the consumer, pharmaceutical, medical devices, and diagnostics markets. The company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Company Name	Johnson & Johnson
Website	www.jnj.com
Established Time	1890
Manufacturing Bases	America, Europe, Asia, etc.
Sales Region	Worldwide
Headquarters	USA
Product Introduction	Blink® Tears Lubricating Eye Drops Product Overview: Treating patients with mild to moderate dry eye symptoms. The product has a hypotonic, viscoelastic formula that mimics human tears, thereby thickening quickly and helping to stabilize the tear film. It maximizes hydration while making the eyes gentle.

Market Challenges

The most common side effect of artificial tears is temporary blurred vision. Prescription eye drops can have additional side effects, such as burning, redness, pain, and foreign body sensations that can give users a bad experience. How to improve the product and reduce harm is a big challenge. At the same time, preservatives in artificial tears may be toxic and may damage the corneal epithelium, which not only limits the growth of the market but also may cause irreparable losses to consumers.